Authors
Guangwei Li, Kexin Wang, Dongliang Zhang, Xinzhu Wang, Haidong He, Yu Chen
Published in
Journal of materials chemistry. B. Nov 20, 2026. Epub Nov 20, 2026.
Abstract
This enzyme-free anti-interference strategy for serum creatinine detection operates independently of biological enzyme reagents such as creatininase. It enables accurate quantification of serum creatinine via materials engineering and electrochemical technologies, while effectively eliminating a wide range of interfering factors. This detection scheme addresses a critical limitation of traditional enzymatic methods, namely their high susceptibility to interference from coexisting substances including IgM proteins, bilirubin and catecholamines. In the present work, a highly selective enzyme-free bilayer multifunctional hydrogel was developed for rapid creatinine detection. The upper PDADMAC/PVA hydrogel serves as a purification layer, which can efficiently remove or suppress the interference from coexisting biomolecules in blood through electrostatic adsorption. The underlying functional layer is constructed with a BPQDs-(Ag/PA)/PVA hydrogel serving as the electroactive recognition element. Leveraging the multi-component synergistic effect among black phosphorus quantum dots, silver nanoparticles and picric acid, cascaded amplification of the electrochemical response signal is achieved after the Jaffé reaction. The as-fabricated sensor exhibits an optimal linear relationship within 0-200 µM, with a low limit of detection down to 1.599 µM. Through 10-fold pre-dilution of serum samples and subsequent correction with the dilution factor, the indirect quantitative range for creatinine is successfully expanded to 2000 µM. This sensing platform demonstrates exceptional anti-interference ability against common coexisting substances in serum, and its test results are in excellent agreement with hospital clinical measurements, fully validating its application reliability in complex real biological matrices. Follow-up research will further break through the pre-treatment limitation to realize direct label-free detection of undiluted original serum specimens.
PMID:
43063353
Bibliographic data and abstract were imported from PubMed on 21 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0